Add Yahoo as a preferred source to see more of our stories on Google. Doses of the COVID antiviral drug Paxlovid are displayed in New York on Aug. 1, 2022. (Stephanie Nano / Associated Press) The ...

DEAR DR. ROACH: I foolishly was in a crowded indoor location and got COVID (for the third time). I thought about getting Paxlovid. But I figured, heck, I’m healthy and vaccinated; I’ll just tough it ...

Paxlovid is an antiviral therapy that helps your body fight off COVID-19 faster and more effectively. In one clinical trial, Paxlovid was 89% effective in reducing hospitalization and death in ...

Ducharme is a contributor to TIME. Pfizer's drug Paxlovid on display in Pembroke Pines, Fla., on July 7, 2022. Ducharme is a contributor to TIME. Taking the COVID-19 antiviral Paxlovid does not appear ...

With COVID-19 cases again on the upswing, the antiviral Paxlovid has been slow to gain traction among patients and doctors even though the medication reduces hospitalizations and deaths. A recent ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

Paxlovid, one of the most well-known treatments for COVID-19, has also been shown to ease symptoms of some patients with long COVID — and new research suggests the antiviral medication could prove to ...

A recent patient-led case series highlights the potential benefits of extended courses of Pfizer Inc's (NYSE:PFE) Paxlovid (nirmatrelvir / ritonavir) for individuals with Long COVID. The study ...

Dear Doctors: Our dad is 77 years old and has diabetes. He got sick with COVID-19 this summer, and it was a huge struggle to get him to take the Paxlovid his doctor prescribed. The process made me ...

The United States suffers from a litany of policy failures in the response to covid-19. Low vaccine uptake in vulnerable populations such as nursing homes remains a major problem, as does the lack of ...

But the slogan, catchy though it may be, belies a harsher reality that some public health and elected officials have long acknowledged and worked to rectify: For many, getting access to the ...

With COVID-19 cases again on the upswing, the antiviral Paxlovid has been slow to gain traction among patients and doctors even though the medication reduces hospitalizations and deaths. A recent ...